Check out our most popular compounded medications! Get Started
Morphine Sulfate 400 mg Slow Release Capsules are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used for the management of chronic, cancer, postoperative, neuropathic, and arthritis pain.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 400 mg Slow Release Capsules are a potent, long-acting opioid analgesic specifically formulated to manage moderate to severe chronic pain. This unique formulation incorporates Methocel E4M, a type of controlled-release polymer, which is designed to gradually release the encapsulated medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and thereby improving patient compliance.
However, it is crucial to note that this formulation is not suitable for the treatment of acute pain. It is specifically designed for chronic pain management and should be used accordingly.
Patients should be aware that Morphine Sulfate 400 mg Slow Release Capsules can cause side effects such as drowsiness, dizziness, and confusion. Therefore, it is advised not to operate heavy machinery or drive while on this medication. Furthermore, due to the potential for addiction and abuse associated with opioid medications, patients should strictly adhere to the prescribed dosage and schedule.
Healthcare providers prescribing this formulation should also be cognizant of its intended use for chronic pain management only. They should be vigilant for signs of misuse or abuse in their patients, given the potential for addiction associated with this class of medication.
If you have any questions or concerns regarding Morphine Sulfate 400 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your medication needs and to provide you with the necessary information to ensure safe and appropriate use of your prescribed medication.
Morphine Sulfate 400 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period of time, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, including those used to treat depression, anxiety, pain, and sleep disorders. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Additionally, any allergies or medical conditions that may affect the body's metabolism of the medication should be disclosed to the healthcare provider.
Patients should be aware that Morphine Sulfate 400 mg Slow Release Capsules may increase the risk of side effects such as drowsiness, confusion, and difficulty breathing, especially when interacting with other medications. The use of alcohol or other central nervous system depressants in conjunction with these capsules may increase the risk of serious side effects and is therefore not recommended.
Interactions may also occur with other medications such as anticoagulants, anti-seizure medications, and certain antibiotics. Patients taking any of these medications should inform their healthcare provider as they may need to be monitored more closely.
If you have any questions about the interactions of Morphine Sulfate 400 mg Slow Release Capsules with other medications, please consult with your healthcare provider or pharmacist.
Morphine Sulfate 400 mg Slow Release Capsules are a potent, extended-release pain medication designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the encapsulated morphine sulfate over an extended period. This slow-release mechanism provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for those requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once a day, and should be swallowed whole with a full glass of water. Consistency in the timing of administration is crucial to maintain a steady level of medication in the body, thereby ensuring optimal pain management. Morphine Sulfate 400 mg Slow Release Capsules are indicated for a variety of conditions causing moderate to severe pain, including cancer, arthritis, and post-surgical pain.
The medication functions by inhibiting pain signals from reaching the brain, thereby providing relief. It is important to note that Morphine Sulfate 400 mg Slow Release Capsules are not intended for the treatment of mild pain or pain that can be effectively managed with over-the-counter medications.
As with any medication, Morphine Sulfate 400 mg Slow Release Capsules may cause side effects, such as nausea, constipation, dizziness, and drowsiness. It is essential to discuss any side effects experienced with your healthcare provider. Additionally, it is crucial to inform your healthcare provider of any other medications you are currently taking, as potential interactions may occur with Morphine Sulfate 400 mg Slow Release Capsules.
If you have any questions or concerns regarding Morphine Sulfate 400 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist. They are equipped with the knowledge and resources to help you navigate your pain management journey.
Morphine Sulfate 400 mg Slow Release Capsules are a potent analgesic formulation designed to provide extended relief from various types of pain. These include chronic pain, cancer pain, postoperative pain, neuropathic pain, arthritis pain, musculoskeletal pain, and fibromyalgia. The slow-release feature, facilitated by Methocel E4M, a controlled-release polymer, ensures a gradual release of the active ingredient over an extended period. This results in sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
In addition to pain management, Morphine Sulfate 400 mg Slow Release Capsules can also be used to treat opioid-induced constipation, opioid withdrawal symptoms, and chronic cough. The slow-release formulation ensures that the medication is delivered in a controlled manner, reducing the risk of side effects and improving overall patient comfort and compliance.
Morphine Sulfate 400 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
The Morphine Sulfate 400 mg Slow Release Capsules work by gradually releasing the active ingredient, morphine sulfate, over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M.
The frequency of dosing will depend on your doctor's prescription. However, the slow-release formulation is designed to reduce the frequency of dosing compared to traditional formulations.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up. Always follow your doctor's instructions.
Like all medications, Morphine Sulfate 400 mg Slow Release Capsules can have side effects. These can include nausea, vomiting, constipation, lightheadedness, dizziness, or drowsiness. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
No, you should not crush or break the capsules. Doing so can release all of the drug at once, increasing the risk of morphine overdose.
Always inform your doctor about all the medications you are currently taking, including prescription and non-prescription drugs, vitamins, and herbal supplements. Some medications may interact with Morphine Sulfate 400 mg Slow Release Capsules, affecting how it works or increasing the risk of side effects.
People with certain medical conditions, such as severe asthma or breathing problems, a blockage in the stomach or intestines, or a hypersensitivity to morphine, should not take Morphine Sulfate 400 mg Slow Release Capsules. Always consult your doctor before starting any new medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
